Search

Search Funnelback University

Search powered by Funnelback
Your query has been expanded to `autoimmune disease lupus` |u:www.enterprize.cam.ac.uk.  Search for `autoimmune disease lupus` |u:www.enterprise.cam.ac.uk instead.
1 - 13 of 13 search results for `autoimmune disease lupus` |u:www.enterprise.cam.ac.uk or `autoimmune disease lupus` |u:www.enterprize.cam.ac.uk
  1. Fully-matching results

  2. Cambridge spin-out PredictImmune closes Series B, raising £10m –…

    https://www.enterprise.cam.ac.uk/news/cambridge-spin-out-predictimmune-closes-series-b-raising-10m/
    Thumbnail for Cambridge spin-out PredictImmune closes Series B, raising £10m – Cambridge Enterprise 22 Feb 2023: It also allows the organisation to expand its horizons in terms of product development— expanding existing activities in inflammatory bowel disease (IBD) as well as into a range of additional autoimmune ... Immune-mediated diseases, such as IBD and SLE,
  3. SLE Archives – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/tag/sle/feed/
    21 Jun 2024: pThe company’s existing worldwide license covers technology—including algorithms and software—relating to the prediction of disease outcome in relapsing-remitting autoimmune and inflammatory disease, specifically inflammatory bowel disease (IBD
  4. ken smith Archives – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/tag/ken-smith/feed/
    21 Jun 2024: pThe company’s existing worldwide license covers technology—including algorithms and software—relating to the prediction of disease outcome in relapsing-remitting autoimmune and inflammatory disease, specifically inflammatory bowel disease (IBD
  5. Paul Kinnon Archives – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/tag/paul-kinnon/feed/
    21 Jun 2024: pThe company’s existing worldwide license covers technology—including algorithms and software—relating to the prediction of disease outcome in relapsing-remitting autoimmune and inflammatory disease, specifically inflammatory bowel disease (IBD
  6. New agreement with Cambridge spin-out PredictImmune lets SLE join…

    https://www.enterprise.cam.ac.uk/news/new-agreement-with-university-spin-out-predictimmune-allows-product-pipeline-to-include-systemic-lupus-erythematosus/
    Thumbnail for New agreement with Cambridge spin-out PredictImmune lets SLE join pipeline – Cambridge Enterprise 22 Feb 2023: The new agreement grants PredictImmune ‘first right of refusal’ to additional technology enabling the prediction of disease outcome for systemic lupus erythematosus (SLE). ... SLE is a form of the autoimmune disease lupus, in which the immune system
  7. BGF Archives – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/tag/bgf/feed/
    21 Jun 2024: Life Sciences Spin-outs Technology Transfer BGF Cambridge innovation capital inflammatory bowel disease ken smith parkwalk Predictimmune PredictSURE IBD systemic lupus erythematosus ... It also allows the organisation to expand its horizons in terms of
  8. PredictSURE IBD Archives – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/tag/predictsure-ibd/feed/
    21 Jun 2024: The US patent is part of PredictImmune’s third family of intellectual property (IP) relating to methods for predicting autoimmune disease risk. ... However, the implication for patients with autoimmune disease is more positive – their exhausted CD8
  9. systemic lupus erythematosus Archives – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/tag/systemic-lupus-erythematosus/feed/
    21 Jun 2024: innovation capital inflammatory bowel disease ken smith parkwalk Predictimmune PredictSURE IBD systemic lupus erythematosus https://camenterprise.dev.twkmedia.com/?post_type=news&p=13108 pCambridge Enterprise portfolio company PredictImmune,
  10. Predictimmune Archives – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/tag/predictimmune/feed/
    21 Jun 2024: of Medicine at the University of Cambridge is further translated into benefits for patients with these additional chronic, debilitating diseases./p pSLE is a form of the autoimmune disease lupus, in ... The US patent is part of PredictImmune’s third
  11. parkwalk Archives – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/tag/parkwalk/feed/
    21 Jun 2024: capital inflammatory bowel disease ken smith parkwalk Predictimmune PredictSURE IBD systemic lupus erythematosus https://camenterprise.dev.twkmedia.com/?post_type=news&p=13108 pCambridge Enterprise portfolio company PredictImmune, developers of
  12. Department of Medicine Archives – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/tag/department-of-medicine/feed/
    21 Jun 2024: remitting autoimmune and inflammatory disease, specifically inflammatory bowel disease (IBD), both Crohn’s and Ulcerative Colitis. ... of Medicine at the University of Cambridge is further translated into benefits for patients with these additional
  13. inflammatory bowel disease Archives – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/tag/inflammatory-bowel-disease/feed/
    21 Jun 2024: The US patent is part of PredictImmune’s third family of intellectual property (IP) relating to methods for predicting autoimmune disease risk. ... However, the implication for patients with autoimmune disease is more positive – their exhausted CD8
  14. Cambridge innovation capital Archives – Cambridge Enterprise

    https://www.enterprise.cam.ac.uk/tag/cambridge-innovation-capital/feed/
    21 Jun 2024: Tue, 30 Jul 2019 08:00:11 0000 Life Sciences Spin-outs Technology Transfer BGF Cambridge innovation capital inflammatory bowel disease ken smith parkwalk Predictimmune PredictSURE IBD systemic lupus erythematosus ... It also allows the organisation to

Related searches for `autoimmune disease lupus` |u:www.enterprise.cam.ac.uk

Search history

Recently clicked results

Recently clicked results

Your click history is empty.

Recent searches

Your search history is empty.